fda compounding semaglutide warning letters september 2025 Why the Issued 30 to Telehealth Sites Marketing Compounded GLP-1s Article: Brazilian Clinics and the
Description
10.1124/jpet.104.073890 [DOI] [PubMed] [Google Scholar] 25.Dutour A, Abdesselam I, Ancel P, Kober F, Mrad G, Darmon P, et al
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, for weight management in specific patient populations
GLP-1 drugs for weight loss grew as a portion of employers' overall medical claims spending to 8.9% in 2024 from 6.9% in 2023
Weight management is not one-size-fits-all
